Insider Selling Cytokinetics, Incorporated EVP Sells 7,300 Shares of Stock
| FBTTX Fund | USD 28.60 0.20 0.69% |
Slightly above 62% of Fidelity Advisor's investor base is looking to short. The analysis of overall sentiment of trading Fidelity Advisor Biotechnology mutual fund suggests that many investors are alarmed at this time. Fidelity Advisor's investing sentiment can be driven by a variety of factors including economic data, Fidelity Advisor's earnings reports, geopolitical events, and overall market trends.
Fidelity |
Cytokinetics, Incorporated EVP Fady Ibraham Malik sold 7,300 shares of Cytokinetics stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of 50.16, for a total value of 366,168.00. Following the sale, the executive vice president now owns 111,878 shares in the
Read at thelincolnianonline.com
 |
Fidelity Advisor Fundamental Analysis
We analyze Fidelity Advisor's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fidelity Advisor using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fidelity Advisor based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Fidelity Advisor is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Fidelity Advisor Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fidelity Advisor mutual fund to make a market-neutral strategy. Peer analysis of Fidelity Advisor could also be used in its relative valuation, which is a method of valuing Fidelity Advisor by comparing valuation metrics with similar companies.
Peers
Fidelity Advisor Related Equities
| VGHCX | Vanguard Health | 0.44 | ||||
| SHSCX | Blackrock Health | 0.28 | ||||
| SHISX | Blackrock Health | 0.27 | ||||
| FSPHX | Health Care | 0.16 | ||||
| VGHAX | Vanguard Health | 0.08 | ||||
| VHCIX | Vanguard Health | 0.10 | ||||
| THISX | T Rowe | 0.12 | ||||
| PRHSX | T Rowe | 0.12 |
Other Information on Investing in Fidelity Mutual Fund
Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |